Reduced combined radiotherapy and chemotherapy for Hodgkin's disease--risk-adapted treatment approach

Recent Results Cancer Res. 1989:117:163-8. doi: 10.1007/978-3-642-83781-4_16.
No abstract available

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bleomycin / administration & dosage
  • Combined Modality Therapy
  • Daunorubicin / administration & dosage
  • Female
  • Hodgkin Disease / drug therapy
  • Hodgkin Disease / radiotherapy
  • Hodgkin Disease / therapy*
  • Humans
  • Lomustine / administration & dosage
  • Male
  • Middle Aged
  • Nitrogen Mustard Compounds / administration & dosage
  • Prednisone / administration & dosage
  • Procarbazine / administration & dosage
  • Risk Factors
  • Vinblastine / administration & dosage
  • Vincristine / administration & dosage

Substances

  • Nitrogen Mustard Compounds
  • Bleomycin
  • Procarbazine
  • Vincristine
  • Vinblastine
  • Lomustine
  • Prednisone
  • Daunorubicin

Supplementary concepts

  • CVPP protocol
  • DBVCy protocol